Table 4.
Randomized Controlled Trials on Local Use of Tranexamic Acid in Soft-Tissue Surgery: Inner Organs, Minimally Invasive Procedures
Reference, Year, Publication Type | TXA Group (total sample size) | Procedure | Concentration of TXA, Volume, Mode of Administration | Comparator | Bleeding * | Postoperative Hemorrhagic Incidence/Intervention/Transfusion † |
---|---|---|---|---|---|---|
Abdullah 2012, conference abstract67 | 52 total | TURP | 0.5 mg/ml in irrigation fluid | Standard irrigation fluid | Drop in Hb (g/dl) on first and second POD; TXA 0.87 and 0.31 vs placebo 0.98 and 0.95 | Not assessed |
Rani 2018, article69 | 30 (60) | TURP | 0.2 mg/ml in irrigation fluid | Standard irrigation fluid | Intraoperative blood loss (ml) TXA = 145 ± 13 vs placebo 198 ± 18, p < 0.01 Drop in Hb (g/dl) TXA = 0.81 ± 0.40 vs. placebo = 1.46 ± 0.37, p < 0.01 |
No transfusions in either group |
Bansal 2017, article68 | 200 (400) | Percutaneous nephrolithotomy | 1 mg/ml in irrigation fluid | Distilled water as placebo in irrigation fluid | Total blood loss (ml) TXA = 155 ± 47 vs placebo 213 ± 68, p < 0.001 | Transfusion need (n): TXA = 10 vs placebo = 25. Need of angioembolization (n): TXA = 1 vs placebo = 8 |
Rasheedy 2019, article70 | 40 (80) | Hysteroscopic myomectomy | 1 mg/ml in distention fluid | Glycine as placebo in distention fluid | Drop in Hb after 24 h (g/dl) TXA = 1.11 ± 0.58 vs placebo = 1.46 ± 0.61, p = 0.001 | Excessive perioperative bleeding reported by surgeon (n): TXA = 1 vs placebo = 9. Good surgical view (n): TXA = 23 vs placebo = 8 |
TXA, tranexamic acid; TURP, transurethral prostatectomy; Hb, hemoglobin; POD, postoperative day.
Values are mean ± SD unless otherwise stated.
Values (n) are number of patients unless otherwise stated.